Enzymaster Completed Series B-1 Financing Round

Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, announced the close of a US$ 7.5 Mio (CNY 50 Mio) Series B-1 funding. The money has been raised from the Chinese investment firms Weifang Zhongke Haichuang Equity Investment Partnership, Tibet Leimerious Venture Investment Partnership, and Caozhixing […]

3rd ECP Summer Summit

Interested in learning more about our services around biocatalysis or our products? We invite you to meet us at the 3rd ECP Summer Summit from September 17th to 18th . This year’s ECP presents itself in a fully digital format and we are looking forward to connect and expand our network of collaborations and partnerships!